| Literature DB >> 29993272 |
Fatiha Brahmi1,2, Anne Vejux1, Randa Sghaier1,3,4, Amira Zarrouk3,4, Thomas Nury1, Wiem Meddeb1,5, Leila Rezig1,6, Amira Namsi1,7, Khouloud Sassi1,8, Aline Yammine1,9, Iham Badreddine1,10, Dominique Vervandier-Fasseur11, Khodir Madani2, Lila Boulekbache-Makhlouf2, Boubker Nasser12, Gérard Lizard1.
Abstract
Cholesterol oxidation products, also named oxysterols, can be formed either by cholesterol auto-oxidation, enzymatically or both. Among these oxysterols, 7-ketocholesterol (7KC) is mainly formed during radical attacks that take place on the carbon 7 of cholesterol. As increased levels of 7KC have been found in the tissues, plasma and/or cerebrospinal fluid of patients with major diseases, especially age-related diseases (cardiovascular diseases, eye diseases, neurodegenerative diseases), some cancers, and chronic inflammatory diseases, it is suspected that 7KC, could contribute to their development. Since 7KC, provided by the diet or endogenously formed, is not or little efficiently metabolized, except in hepatic cells, its cellular accumulation can trigger numerous side effects including oxidative stress, inflammation and cell death. To counteract 7KC-induced side effects, it is necessary to characterize the metabolic pathways activated by this oxysterol to identify potential targets for cytoprotection and geroprotection. Currently, several natural compounds (tocopherols, fatty acids, polyphenols, etc) or mixtures of compounds (oils) used in traditional medicine are able to inhibit the deleterious effects of 7KC. The different molecules identified could be valued in different ways (functional foods, recombinant molecules, theranostic) to prevent or treat diseases associated with 7KC.Entities:
Keywords: 7-ketocholesterol; cytoprotection; geroprotection; natural compounds
Mesh:
Substances:
Year: 2018 PMID: 29993272 DOI: 10.1080/10408398.2018.1491828
Source DB: PubMed Journal: Crit Rev Food Sci Nutr ISSN: 1040-8398 Impact factor: 11.176